Study Design
- Reference for OS diagnosis
- Has this been explored in previous research? TT
- What are the inclusion criteria for outlier patients? TT
- What is the Patient Committee? TT
- What is the 1L treatment? TT
- How does a Center identify and select patients (outliers and controls)? TT
- What is the difference between the 'Results' of the study and 'Raw omic results' of the patients of a given center? TT
- Are there any risks for the participants on the ROSALIND study? TT
- Why does the ROSALIND study cannot reasonably be accomplished without using the personal health information? TT
- Calcul OS TT
- Summary of the ROSALIND study TT
- How will CURE51 provide individualised reports for patients? TT
- What is the rationale of the ROSALIND study? TT
- What is the duration of the ROSALIND study? TT
- What type of study is Rosalind? TT
- How do I estimate the number of long-term survivors? TT